Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer

Medical Oncology

Volumn 29, Issue 2, 2012, Pages 589-594

  Saydam, Ozkan ^a   Gokce, Mertol ^a   Kilicgun, Ali ^b   Tanriverdi, Ozgur ^c  

^a Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

^b ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^c ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Anthracosis; Coal workers' pneumoconiosis; Lymph nodes; Positron emission tomography

Indexed keywords

ANTINEOPLASTIC AGENT; COAL; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ANTHRACOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COAL MINING; COAL WORKER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISTANT METASTASIS; FALSE POSITIVE RESULT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; PNEUMOCONIOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; WHOLE BODY PET; ADENOCARCINOMA; FOLLOW UP; LARGE CELL CARCINOMA; LUNG TUMOR; LYMPH NODE; MEDIASTINUM; METASTASIS; MIDDLE AGED; PATHOLOGY; PLEURA TUMOR; PROGNOSIS; RADIOGRAPHY; SCINTISCANNING; SQUAMOUS CELL CARCINOMA; TURKEY (REPUBLIC);

ADENOCARCINOMA; AGED; ANTHRACOSIS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COAL; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEDIASTINOSCOPY; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TURKEY;

EID: 84866341816     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-9879-y     Document Type: Article

References (24)

1. Bayman NA, Blackhall F, Jain P, Lee L, Thatcher N, et al. Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment. Clin Lung Cancer. 2008;9:92-101.
2. Tieu BH, Sanborn RE, Thomas CR Jr. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement. Thorac Surg Clin. 2008;18:403-15.
3. Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology. 2004;231:305-32.
4. Konishi J, Yamazaki K, Tsukamoto E, Tamaki N, Onodera Y, et al. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDGPET findings. Respiration. 2003;70:500-6.
5. Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology. 2005;236:1011-9.
6. Bakheet S, Powe J. 18-FDG uptake due to benign pathology. Semin Nucl Med. 1998;28:352-8.
7. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med. 1996;23:1409-15.
8. Reichert M, Bensadoun ES. PET imaging in patients with coal workers pneumoconiosis and suspected malignancy. J Thorac Oncol. 2009;4:649-51.
9. Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, et al. Pneumoconiosis: comparison of imaging and pathologic findings. Radio Graphics. 2006;26:59-77.
10. Aydin H. Evaluation of the risk of coal workers pneumoconiosis (CWP): a case study for the Turkish hard coal mining. Sci Res Essays. 2010;5:3289-97.
11. Onito AA, Engel JM, Tanimu SB, Nguyen TC. Anthracosis and large mediastinal mass in a patient with healed pulmonary tuberculosis. Clin Med Res. 2010;8:99-103.
12. Rosell R, Gómez-Codina J, Camps C, Maestre J, Padille J, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med. 1994;330:153-8.
13. Nomori H, Ohba Y, Yoshimoto K, Shibata H, Shiraishi K, et al. Positron emission tomography in lung cancer. Gen Thorac Cardiovasc Surg. 2009;57:184-91.
14. Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. Chest. 2000;117:773-8.
15. Albes JM, Lietzenmayer R, Schott U, Schülen E, Wehrmann M, et al. Improvement of non-small-cell lung cancer staging by means of positron emission tomography. Thorac Cardiovasc Surg. 1999;47:42-7.
16. Vanhee D, Gossett P, Boitelle A, Wallaert B, Tonnee AB. Cytokines and cytokine network in cilicosis and coal workers' pneumoconiosis. Eur Respir J. 1995;8:834-42.
17. Katabami M, Dusaka-Akita H, Honma K, Saitoh Y, Kimura K, et al. Pneumoconiosis-related lung cancer: preferential occurence from diffuse interstitial fibrosis-type pneumoconiosis. Am J Respir Crit Care Med. 2000;162:295-300.
18. Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med. 2002;32:293-321.
19. Argani P, Ghossein R, Rosai J. Anthracotic and anthracosilicotic spindle cell pseudotumors of mediastinal lymph nodes: report of five cases of a reactive lesion that stimulates malignancy. Hum Pathol. 1998;29:851-5.
20. Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, et al. Preoperative intrathoracic lymph node staging in patients with nonsmall- cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg. 2009;36:440-5.
21. Reed CE, Harpole DH, Posther KE, Woolson SL, Bowney RJ, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;126:1943-51.
22. Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist. 2004;9:633-43.
23. Cerfolio RJ, Buddhiwardhan O, Bryant AS, Bass CS, Bartalucci AA, et al. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg. 2003;76:861-6.
24. Lee PC, Port JL, Korst RJ, Liss Y, Meherally DN, et al. Risk factors for occult mediastinal metastases in clinical stage I nonsmall cell lung cancer. Ann Thorac Surg. 2007;84:177-81.